Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)

Nikkei / Financial Times [2015] IECompA m15026 (9 June 2015)

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the relevant market and therefore cleared the merger.

Parties
Acquirer: Baxter Healthcare Limited; Target: Fannin Limited
Jurisdiction
Ireland
Judgment Date
09 June 2015
Procedural Posture
Merger Clearance / Final Determination
Outcome
merger cleared
Legal Topics
Merger Notification, Clearance, Pharmaceutical Sector, Medical Devices

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

Baxter Healthcare Limited

Acquirer

Fannin Limited

Target

Procedural Posture

Merger Clearance / Final Determination

  1. 1 Whether the proposed acquisition would substantially lessen competition in the relevant market

Ratio Decidendi

The Competition and Consumer Protection Commission determined that the proposed acquisition would not substantially lessen competition in the relevant market and therefore cleared the merger.

Court Disposition

merger cleared

Orders

  • The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited is cleared.